Notch signaling in development and disease

Notch receptors and ligands were first identified in flies and worms, where they were shown to regulate cell proliferation, cell differentiation, and, in particular, binary cell fate decisions in a variety of developmental contexts. The first mammalian Notch homolog was discovered to be a partner in a chromosomal translocation in a subset of human T‐cell leukemias. Subsequent studies in mice and humans have shown that Notch signaling plays essential roles at multiple stages of hematopoiesis, and also regulates the development or homeostasis of cells in many tissues and organs. Thus, it is not surprising that mutations which disrupt Notch signaling cause a wide range of cancers and developmental disorders. Perhaps because it is so widely used, Notch signaling is subject to many unusual forms of regulation. In this review, we will first outline key aspects of Notch signaling and its regulation by endocytosis, glycosylation, and ubiquitination. We will then overview recent literature elucidating how Notch regulates cell‐lineage decisions in a variety of developmental contexts. Finally, we will describe the roles of dysregulated Notch signaling in causing several types of cancer and other pathologies.

[1]  T. Lehtimäki,et al.  NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia , 2003, Psychiatric genetics.

[2]  D. Zinyk,et al.  Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila , 1997, Nature Genetics.

[3]  I. Krantz,et al.  Jagged1 mutations in Alagille syndrome , 2001, Human mutation.

[4]  R. Krumlauf,et al.  Dynamic expression patterns of the pudgy/spondylocostal dysostosis gene Dll3 in the developing nervous system , 2001, Mechanisms of Development.

[5]  U. Lendahl,et al.  Mouse Notch 3 expression in the pre- and postnatal brain: relationship to the stroke and dementia syndrome CADASIL. , 2002, Experimental cell research.

[6]  I. Bernstein,et al.  Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. , 2003, Blood.

[7]  Larry Kedes,et al.  HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.

[8]  H. Macdonald,et al.  Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.

[9]  E. Lai.  Protein Degradation: Four E3s For The Notch Pathway , 2002, Current Biology.

[10]  A. Cox,et al.  Identification of novel single nucleotide polymorphisms within the NOTCH4 gene and determination of association with MHC alleles. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[11]  M. Nomura,et al.  Placenta Growth Factor and Vascular Endothelial Growth Factor B and C Expression in Microvascular Endothelial Cells and Pericytes , 1999, The Journal of Biological Chemistry.

[12]  H. Krämer.  Neuralized: regulating notch by putting away delta. , 2001, Developmental cell.

[13]  J. Laborda,et al.  T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells , 1996, The Journal of experimental medicine.

[14]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[15]  F. Kuo,et al.  Isolation and functional analysis of a cDNA for human Jagged2, a gene encoding a ligand for the Notch1 receptor , 1997, Molecular and cellular biology.

[16]  A. Röpke,et al.  Identification of 36 novel Jagged1 (JAG1) mutations in patients with Alagille syndrome , 2003, Human mutation.

[17]  S. Cohen,et al.  Glycosyltransferase activity of Fringe modulates Notch–Delta interactions , 2000, Nature.

[18]  Qiong Shen,et al.  Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. , 2002, Blood.

[19]  D. van der Kooy,et al.  Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. , 2002, Genes & development.

[20]  J. Rossant,et al.  Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Ellard,et al.  Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the Notch signalling pathway, cause a consistent pattern of abnormal vertebral segmentation in spondylocostal dysostosis , 2003, Journal of medical genetics.

[22]  J. Aster,et al.  Notch1 expression in early lymphopoiesis influences B versus T lineage determination. , 1999, Immunity.

[23]  F. Salvi,et al.  An italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) , 1995, Annals of neurology.

[24]  U. Lendahl,et al.  Expression of the Notch 3 intracellular domain in mouse central nervous system progenitor cells is lethal and leads to disturbed neural tube development , 1996, Mechanisms of Development.

[25]  Hans Clevers,et al.  Notch1 functions as a tumor suppressor in mouse skin , 2003, Nature Genetics.

[26]  Ryoichiro Kageyama,et al.  Control of endodermal endocrine development by Hes-1 , 2000, Nature Genetics.

[27]  Horst Hameister,et al.  SHARP is a novel component of the Notch/RBP‐Jκ signalling pathway , 2002 .

[28]  S. Artavanis-Tsakonas,et al.  Notch signaling: cell fate control and signal integration in development. , 1999, Science.

[29]  G. Sedvall,et al.  Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits , 2003, Psychiatric genetics.

[30]  Jon C. Aster,et al.  Essential Roles for Ankyrin Repeat and Transactivation Domains in Induction of T-Cell Leukemia by Notch1 , 2000, Molecular and Cellular Biology.

[31]  M. Bevan,et al.  Surface Expression of Notch1 on Thymocytes: Correlation with the Double-Negative to Double-Positive Transition 1 , 2003, The Journal of Immunology.

[32]  T. Gridley.  Notch Signaling in Vertebrate Development and Disease , 1997, Molecular and Cellular Neuroscience.

[33]  C. Tabin,et al.  A Somitic Compartment of Tendon Progenitors , 2003, Cell.

[34]  Paul S. Meltzer,et al.  Mutations in the human Jagged1 gene are responsible for Alagille syndrome , 1997, Nature Genetics.

[35]  H. Macdonald,et al.  Notch 1–Deficient Common Lymphoid Precursors Adopt a B Cell Fate in the Thymus , 2001, The Journal of experimental medicine.

[36]  R. Callahan,et al.  Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines , 2000, Oncogene.

[37]  J. Rossant,et al.  Notch1 is required for the coordinate segmentation of somites. , 1995, Development.

[38]  D. Scadden,et al.  Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. , 2002, Blood.

[39]  R. Hruban,et al.  Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. , 2003, Cancer cell.

[40]  U. Lendahl,et al.  Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.

[41]  H. Macdonald,et al.  Inactivation of Notch1 in immature thymocytes does not perturb CD4 or CD8 T cell development , 2001, Nature Immunology.

[42]  B. Fowlkes,et al.  A Reassessment of the Effect of Activated Notch1 on CD4 and CD8 T Cell Development1 , 2002, The Journal of Immunology.

[43]  I. Bernstein,et al.  Notch signalling in hematopoiesis. , 2003, Seminars in cell & developmental biology.

[44]  I. Bernstein,et al.  Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling , 2000, Nature Medicine.

[45]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[46]  Wenli Wang,et al.  Notch3 Signaling in Vascular Smooth Muscle Cells Induces c-FLIP Expression via ERK/MAPK Activation , 2002, The Journal of Biological Chemistry.

[47]  B. Birren,et al.  The mouse pudgy mutation disrupts Delta homologue Dll3 and initiation of early somite boundaries , 1998, Nature Genetics.

[48]  David J. Anderson,et al.  Notch signalling controls pancreatic cell differentiation , 1999, Nature.

[49]  L. Strobl,et al.  EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. , 2001, Seminars in cancer biology.

[50]  G. Weinmaster,et al.  Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2 , 2000, Nature Cell Biology.

[51]  J. Sklar,et al.  Notch1-Induced Delay of Human Hematopoietic Progenitor Cell Differentiation Is Associated With Altered Cell Cycle Kinetics , 1999 .

[52]  Kenji Nakata,et al.  NOTCH4 gene polymorphism and susceptibility to schizophrenia and schizoaffective disorder , 2001, Neuroscience Letters.

[53]  D. Gallahan,et al.  The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4) , 1997, Oncogene.

[54]  B. Dubois,et al.  Clinical spectrum of CADASIL: a study of 7 families , 1995, The Lancet.

[55]  G. Weinmaster,et al.  Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice. , 1998, Genes & development.

[56]  Freddy Radtke,et al.  Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation , 2001, The EMBO journal.

[57]  M. H. Angelis,et al.  Maintenance of somite borders in mice requires the Delta homologue Dll1 , 1997, Nature.

[58]  J. Weissenbach,et al.  Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients , 1997, The Lancet.

[59]  Eric S. Lander,et al.  Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls , 2001, Nature Genetics.

[60]  David J Anderson,et al.  Transient Notch Activation Initiates an Irreversible Switch from Neurogenesis to Gliogenesis by Neural Crest Stem Cells , 2000, Cell.

[61]  M. Reiser,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: decrease in regional cerebral blood volume in hyperintense subcortical lesions inversely correlates with disability and cognitive performance. , 2001, AJNR. American journal of neuroradiology.

[62]  S. Faraone,et al.  Family-based association study of the NOTCH4 gene in schizophrenia using Japanese and Chinese samples , 2003, Biological Psychiatry.

[63]  M. Gurney,et al.  The Notch Intracellular Domain Is Ubiquitinated and Negatively Regulated by the Mammalian Sel-10 Homolog* , 2001, The Journal of Biological Chemistry.

[64]  J. Burgunder,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a clinicopathological and genetic study of a Swiss family. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[65]  M. Gurney,et al.  SEL-10 Is an Inhibitor of Notch Signaling That Targets Notch for Ubiquitin-Mediated Protein Degradation , 2001, Molecular and Cellular Biology.

[66]  F. Chapon,et al.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.

[67]  G. Tonon,et al.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway , 2003, Nature Genetics.

[68]  J. Brillault,et al.  Lessons from CADASIL , 2002, Annals of the New York Academy of Sciences.

[69]  H. Chabriat,et al.  Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis , 2001, The Lancet.

[70]  H. Macdonald,et al.  The role of Notch signaling during hematopoietic lineage commitment , 2002, Immunological reviews.

[71]  L. Scorrano,et al.  Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT , 2001, Nature Immunology.

[72]  E. Robey,et al.  Notch signaling in lymphocyte development. , 2001, Current opinion in genetics & development.

[73]  Jun Wei,et al.  The NOTCH4 locus is associated with susceptibility to schizophrenia , 2000, Nature Genetics.

[74]  J. Weissenbach,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12 , 1993, Nature Genetics.

[75]  N. Spinner,et al.  Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage. , 2003, American journal of human genetics.

[76]  J. Rossant,et al.  Conservation of the Notch signalling pathway in mammalian neurogenesis. , 1997, Development.

[77]  J. Aster,et al.  An Invitation to T and More Notch Signaling in Lymphopoiesis , 2002, Cell.

[78]  U. Lendahl,et al.  A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  I. Krantz,et al.  Features of alagille syndrome in 92 patients: Frequency and relation to prognosis , 1999, Hepatology.

[80]  Nigel K. Spurr,et al.  Failure to confirm NOTCH4 association with schizophrenia in a large population-based sample from Scotland , 2001, Nature Genetics.

[81]  C. McGlade,et al.  Mammalian Numb Proteins Promote Notch1 Receptor Ubiquitination and Degradation of the Notch1 Intracellular Domain* , 2003, Journal of Biological Chemistry.

[82]  K D Irvine,et al.  A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. , 1997, Development.

[83]  K. Irvine,et al.  Fringe modulates Notch–ligand interactions , 1997, Nature.

[84]  J. Minna,et al.  Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. , 2000, Journal of the National Cancer Institute.

[85]  Gord Fishell,et al.  Radial Glial Identity Is Promoted by Notch1 Signaling in the Murine Forebrain , 2000, Neuron.

[86]  Keith Brennan,et al.  CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? , 2002, Current opinion in genetics & development.

[87]  E. Lander,et al.  Mutations in the human Delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis , 2000, Nature Genetics.

[88]  W. Pear,et al.  Notch signaling in lymphopoiesis. , 2003, Seminars in immunology.

[89]  J. Aster,et al.  Deltex1 redirects lymphoid progenitors to the B cell lineage by antagonizing Notch1. , 2002, Immunity.

[90]  U. Lendahl,et al.  Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[91]  S. Ogawa,et al.  Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. , 2003, Immunity.

[92]  M G McInnis,et al.  Genetic analysis of the (CTG)n NOTCH4 polymorphism in 65 multiplex bipolar pedigrees , 2002, Psychiatric genetics.

[93]  J. R. Coleman,et al.  Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. , 1999, Development.

[94]  I. Greenwald,et al.  LIN-12/Notch signaling: lessons from worms and flies. , 1998, Genes & development.

[95]  Cheryl Wolting,et al.  LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin‐dependent degradation , 2002, The EMBO journal.

[96]  G. Weinmaster,et al.  Notch1 is essential for postimplantation development in mice. , 1994, Genes & development.

[97]  Yang Wang,et al.  Fringe is a glycosyltransferase that modifies Notch , 2000, Nature.

[98]  H. Macdonald,et al.  Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. , 2001, Nature immunology.

[99]  T. Hunter,et al.  Recognition and Ubiquitination of Notch by Itch, a Hect-type E3 Ubiquitin Ligase* , 2000, The Journal of Biological Chemistry.

[100]  S. Egan,et al.  Subversion of the T/B lineage decision in the thymus by lunatic fringe-mediated inhibition of Notch-1. , 2001, Immunity.

[101]  M. Bhatia,et al.  The Notch Ligand Jagged-1 Represents a Novel Growth Factor of Human Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[102]  A. Diévart,et al.  Involvement of Notch1 in the development of mouse mammary tumors , 1999, Oncogene.

[103]  B. Dubois,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval. , 1996, American journal of human genetics.

[104]  D. Clair,et al.  A family-based and case-control association study of the NOTCH4 gene and schizophrenia , 2002, Molecular Psychiatry.

[105]  T. Gridley,et al.  Defects in somite formation in lunatic fringe-deficient mice , 1998, Nature.

[106]  K D Irvine,et al.  Fringe, Notch, and making developmental boundaries. , 1999, Current opinion in genetics & development.

[107]  H. Macdonald,et al.  Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. , 2002, Immunity.

[108]  Toshihito Suzuki,et al.  The (CTG)n polymorphism in the NOTCH4 gene is not associated with schizophrenia in Japanese individuals , 2001, BMC psychiatry.

[109]  J. Sundberg,et al.  Notch signaling is essential for vascular morphogenesis in mice. , 2000, Genes & development.

[110]  C. Guidos,et al.  Fine-tuning Notch1 activation by endocytosis and glycosylation. , 2003, Seminars in immunology.

[111]  M. Dettke,et al.  Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. , 2002, Blood.

[112]  A. Capobianco,et al.  Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. , 2003, Cancer cell.

[113]  S. Munro,et al.  The Notch signalling regulator Fringe acts in the Golgi apparatus and requires the glycosyltransferase signature motif DxD , 2000, Current Biology.

[114]  Anirvan Ghosh,et al.  Nuclear Notch1 signaling and the regulation of dendritic development , 2000, Nature Neuroscience.

[115]  I. Krantz,et al.  Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization. , 1997, American journal of medical genetics.

[116]  T. Gridley,et al.  Segmentation defects of Notch pathway mutants and absence of a synergistic phenotype in lunatic fringe/radical fringe double mutant mice , 2002, Genesis.

[117]  C. Little,et al.  Developmental Biology of the Vascular Smooth Muscle Cell: Building a Multilayered Vessel Wall , 1999, Journal of Vascular Research.

[118]  G. Weinmaster,et al.  An Activated Form of Notch Influences the Choice between CD4 and CD8 T Cell Lineages , 1996, Cell.

[119]  P. Simpson,et al.  Requirement for dynamin during Notch signaling in Drosophila neurogenesis. , 1997, Developmental biology.

[120]  G. Weinmaster,et al.  Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. , 1999, Human molecular genetics.

[121]  I. Weissman,et al.  Lymphocyte development from hematopoietic stem cells. , 2001, Current opinion in genetics & development.

[122]  M. Bevan,et al.  Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. , 2000, Immunity.

[123]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[124]  R. Beddington,et al.  Axial skeletal defects caused by mutation in the spondylocostal dysplasia/pudgy gene Dll3 are associated with disruption of the segmentation clock within the presomitic mesoderm. , 2002, Development.

[125]  S. Aizawa,et al.  Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. , 2003, Immunity.

[126]  J. Lewis,et al.  Notch signalling and the control of cell fate choices in vertebrates. , 1998, Seminars in cell & developmental biology.

[127]  Yvonne A. Evrard,et al.  lunatic fringe is an essential mediator of somite segmentation and patterning , 1998, Nature.

[128]  J. Rohn,et al.  Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma , 1996, Journal of virology.

[129]  Colin C. Collins,et al.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 , 1997, Nature Genetics.

[130]  Horst Hameister,et al.  SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. , 2002, The EMBO journal.

[131]  R. Shigemoto,et al.  Two mammalian helix-loop-helix factors structurally related to Drosophila hairy and Enhancer of split. , 1992, Genes & development.

[132]  J. Hald,et al.  Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development. , 2003, Developmental biology.

[133]  O. Pourquié,et al.  When body segmentation goes wrong , 2001, Clinical genetics.

[134]  G. Huang,et al.  A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. , 2001, Blood.

[135]  R. Tazi-Ahnini,et al.  Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata , 2003, Human Genetics.